Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002034373-24-000001
Filing Date
2024-08-26
Accepted
2024-08-26 16:47:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4653
  Complete submission text file 0002034373-24-000001.txt   6088
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Subject) CIK: 0001261249 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88159 | Film No.: 241242045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 167 HIGHLAND ROAD INVERNESS IL 60067
Business Address
Mastrangeli Doug (Filed by) CIK: 0002034373 (see all company filings)

Type: SCHEDULE 13G